Doctor profile · Federal record
Dr. James Levine, DO
Rheumatology Physician (CMS: Rheumatology) · Greeley, CO
- NPI 1093793838
- Accepts Medicare
- MIPS 93.3 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1675 18Th Ave, Suite 3
Greeley, CO 806315132
(970) 350-2433
fax (970) 392-4768
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- August 31, 2015
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Colorado #42160
- Medicaid
- CO #42052734
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1093793838. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
140,306
Distinct HCPCS
10
Medicare allowed
$2,217,181
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 69,120 | 18 | $6 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 22,650 | 35 | $41 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 21,156 | 26 | $13 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 17,430 | 22 | $10 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 4,650 | 28 | $33 | |
J0897 |
Injection, denosumab, 1 mg | 2,340 | 28 | $23 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 581 | 144 | $67 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 501 | 268 | $130 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 406 | 121 | $126 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 344 | 95 | $29 |
In context: peer comparison
Among 3 peers in Greeley Rheumatology Physician, average services per provider: 3,924. This provider delivers 36× the peer median.Open Payments
Industry payments received
All-time total
$20,972
Transactions
27
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genzyme Corporation | 20 | $20,341.02 | |
| AstraZeneca Pharmaceuticals Lp | 3 | $300.36 | |
| Janssen Biotech, INC. | 1 | $117.52 | |
| Ucb, INC. | 1 | $107.45 | |
| Amgen INC. | 1 | $89.01 | |
| GlaxoSmithKline, LLC. | 1 | $16.94 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,369
Patients
687
Total drug cost
$624,933
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 689 | 197 | $26,457 |
| Hydroxychloroquine Sulfate | Generic | 351 | 94 | $25,069 |
| Prednisone | Generic | 344 | 137 | $3,537 |
| Allopurinol | Generic | 168 | 52 | $3,497 |
| Leflunomide | Generic | 167 | 59 | $13,383 |
| Folic Acid | Generic | 126 | 41 | $620 |
| Tramadol Hcl | Generic | 105 | 16 | $627 |
| Humira(Cf) Pen (Adalimumab) | Brand | 71 | 0 | $532,061 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 62 | 0 | $1,059 |
| Methylprednisolone | Generic | 57 | 33 | $1,374 |
Hospital affiliations
Frequently asked questions
What is Dr. James Levine's medical specialty?
Dr. James Levine practices Rheumatology Physician in Greeley, CO.
Where does Dr. James Levine practice?
Dr. James Levine practices at 1675 18Th Ave, Greeley, CO 806315132. Office phone: 9703502433.
What is Dr. James Levine's NPI?
Dr. James Levine's National Provider Identifier (NPI) is 1093793838, issued by NPPES.
Does Dr. James Levine accept Medicare assignment?
Yes. Dr. James Levine accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. James Levine commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.